Product Images Docetaxel

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 17 images provide visual information about the product associated with Docetaxel NDC 70700-176 by Xiromed Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Docetaxel Injection SPL Carton 16mL

Docetaxel Injection SPL Carton 16mL

This text is a description of Docetaxel, a cytotoxic agent used for intravenous injections. It has a concentration of 160 mg/16 mL and comes in a 1x16 mL multiple-dose vial. It warns to keep it out of reach of children and requires a check of the concentration before preparation. The vial can be used for 28 days after the first use when stored between 2°C to 8°C protected from light. The usual dosage and handling information can be found in the package insert. The product is manufactured for Xiromed LLC and is a product of India.*

Docetaxel Injection SPL Carton 2mL

Docetaxel Injection SPL Carton 2mL

Docetaxel Injection SPL Carton 8mL

Docetaxel Injection SPL Carton 8mL

This is a description for Docetaxel Injection which is a cytotoxic agent and should only be used intravenously. The solution comes in a 1x8mL multiple-dose vial and is ready to add to an infusion solution. Each mL of the solution contains 10 mg Docetaxel Anhydrous USP, and additional ingredients such as Polysorbate, Citric Acid, Dehydrated Alcohol with Polyethylene Glycol. The product is manufactured in India and imported by Xiromed, LLC in Florham Park, NJ. The package insert contains complete instructions and should be referred to check the concentration prior to preparation. After first use, the vials should be stored between 2° to 8°C (36° to 46°F) and protected from light.*

Docetaxel-Injection-SPL-Figure-10 - Docetaxel Injection SPL Figure 10

Docetaxel-Injection-SPL-Figure-10 - Docetaxel Injection SPL Figure 10

Docetaxel-Injection-SPL-Figure-3 - Docetaxel Injection SPL Figure 3

Docetaxel-Injection-SPL-Figure-3 - Docetaxel Injection SPL Figure 3

This is a graph displaying the cumulative probability of overall survival for a specific medical treatment. The survival time is measured in months and the data was analyzed using the log-rank statistical test, resulting in a p-value of 0.010. The graph shows the probability of survival at different time points, with the line for "Fos5" representing a higher probability of survival compared to the line for "Fo.2".*

Docetaxel-Injection-SPL-Figure-4 - Docetaxel Injection SPL Figure 4

Docetaxel-Injection-SPL-Figure-4 - Docetaxel Injection SPL Figure 4

This is a graph showing the cumulative probability of survival over time (in months) for a certain group. The x-axis represents survival time, while the y-axis shows the cumulative probability of survival. The graph also includes a statistical test result, indicating that there was no significant difference in survival between the groups (Log-rank p = 0.13).*

Docetaxel-Injection-SPL-Figure-5 - Docetaxel Injection SPL Figure 5

Docetaxel-Injection-SPL-Figure-5 - Docetaxel Injection SPL Figure 5

This appears to be a graph displaying the survival probability over time (in months). The survival probability is not quantified and no additional information is given, so the context and purpose of the graph is unknown.*

Docetaxel-Injection-SPL-Figure-6 - Docetaxel Injection SPL Figure 6

Docetaxel-Injection-SPL-Figure-6 - Docetaxel Injection SPL Figure 6

Docetaxel-Injection-SPL-Figure-7 - Docetaxel Injection SPL Figure 7

Docetaxel-Injection-SPL-Figure-7 - Docetaxel Injection SPL Figure 7

This is not-available as the given text is incomplete and unclear.*

Docetaxel-Injection-SPL-Figure-8 - Docetaxel Injection SPL Figure 8

Docetaxel-Injection-SPL-Figure-8 - Docetaxel Injection SPL Figure 8

Docetaxel-Injection-SPL-Figure-9 - Docetaxel Injection SPL Figure 9

Docetaxel-Injection-SPL-Figure-9 - Docetaxel Injection SPL Figure 9

Docetaxel-Injection-SPL-Structure - Docetaxel Injection SPL Structure

Docetaxel-Injection-SPL-Structure - Docetaxel Injection SPL Structure

Docetaxel Injection SPL Vial 16mL

Docetaxel Injection SPL Vial 16mL

Docetaxel Injection, USP is a cytotoxic agent that comes in a one-vial formulation. Each mL of the injection contains 10 mg of Docetaxel, 160 mg/16 m Anhydrous USP, 260 mg Polysorbate 80 NF, 4 mg Anhydrous Citric Acid, and 23% v/v Dehydrated Alcohol USP. The injection is for intravenous use only and should be stored at 20° to 25°C, protected from light. It is ready to add to an infusion solution but the concentration should be checked prior to preparation. See the package insert for complete instructions and usual dosage. The product is manufactured for Xiromed, LLC and is a product of India.*

Docetaxel Injection SPL Vial 2mL

Docetaxel Injection SPL Vial 2mL

Docetaxel Injection, USP is a cytotoxic agent in a 2 mL Single-dose vial, with a strength of 20 mg/2 mL (10 mg/mL) for intravenous use only. It is manufactured by Xiromed LLC, and it is a one-vial formulation that is ready to add to infusion solution. The unused portion of the vial should be discarded. It is essential to verify the concentration before preparation, and complete instructions can be found in the package insert. It should be stored at 20° to 25°C. The provided code is AP/DRUGS/03/20T11, and the text mentions that the area is 15 x 8§ mm.*

Docetaxel Injection SPL Vial 8mL

Docetaxel Injection SPL Vial 8mL

This is a description of a medication labeled as NDC 70700-175-22, which is Docetaxel Injection, USP to be administered intravenously. The medication is manufactured by Xiromed, LLC, and consists of 260mg of Docetaxel, along with other ingredients such as polysorbate 80 NF, anhydrous citric acid USP, and dehydrated alcohol. The medication is a cytotoxic agent and should be handled with caution. It comes in an 8mL multiple-dose vial that should be stored at 20° to 25°C and protected from light. The usual dosage and other instructions are provided in the package insert. The lot number is "Un Varnish Area," and the expiration date is "20x 15 mm."*

Docetaxel-Injection-SPL-Figure-1 - docetaxel injection spl figure 1

Docetaxel-Injection-SPL-Figure-1 - docetaxel injection spl figure 1

Docetaxel-Injection-SPL-Figure-2 - docetaxel injection spl figure 2

Docetaxel-Injection-SPL-Figure-2 - docetaxel injection spl figure 2

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.